Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;9(9):e88.
doi: 10.1016/S2213-2600(21)00278-2. Epub 2021 Jul 2.

Lung transplantation for COVID-19-associated ARDS

Philipp M Lepper  1 , Frank Langer  2 , Heinrike Wilkens  3 , Hans-Joachim Schäfers  2 , Robert Bals  3
Affiliations
Comment

Lung transplantation for COVID-19-associated ARDS

Philipp M Lepper et al. Lancet Respir Med. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

HW reports consulting fees from Actelion, Bayer, and Janssen; and speaker's fees from Actelion, Bayer, Biotest, Boehringer Ingelheim, Janssen, MSD, Pfizer, and Roche, outside the submitted work. RB received research funding from the German Center for Lung Research (Deutsches Zentrum für Lungenforschung) for the COPD and SYstemic consequences-COmorbidities NETwork (COSYCONET; grant number 82DZLI05A2) cohort study, and from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF; grant number 01GI0881); and grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Grifols, and Novartis, during the preparation of this Correspondence. RB reports grants from BMBF for the Competence Network on Asthma and COPD (AsCoNet) and from Sander-Stiftung, Krebshilfe, and Mukoviszidose e.V.; grants and personal fees from AstraZeneca, Boehringer Ingelheim, and Novartis; and personal fees from CSL Behring, GlaxoSmithKline, and Grifols, outside the submitted work. All other authors declare no competing interests.

Comment in

Comment on

References

    1. Bharat A, Machuca TN, Querrey M, et al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir Med. 2021;9:487–497. - PMC - PubMed
    1. Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8:1201–1208. - PMC - PubMed
    1. Langer F, Aliyev P, Schäfers HJ, et al. Improving outcomes in bridge-to-transplant: extended extracorporeal membrane oxygenation support to obtain optimal donor lungs for marginal recipients. ASAIO J. 2019;65:516–521. - PubMed
    1. Gottlieb J, Smits J, Schramm R, et al. Lung transplantation in Germany since the introduction of the lung allocation score. Dtsch Arztebl Int. 2017;114:179–185. - PMC - PubMed
    1. Riou J, Boëlle PY, Christie JD, Thabut G. High emergency organ allocation rule in lung transplantation: a simulation study. ERJ Open Res. 2017;3:00020–02017. - PMC - PubMed